Openbookopenbook
Equity
DSwiss Inc(DQWS)
USD --+0.00%
Reward38Moderate
Risk31Moderate
📊75%Data
Thin -1% profit margin · Revenue down 57% YoY
DQWS
+0.0 · +0.00%
USD · PINK
DSwiss Inc | Consumer Defensive
Earnings Deterioration
Market Cap:5.38M
ℹ️
Reward Rating
38
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
31
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on DQWS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is DSwiss Inc?

, a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China.

DQWS · Verdict

Limited reward · moderate risk

DQWS stands out on balance sheet and volatility, but watch the valuation signal.

Based on 88% data coverage

DQWS · Verdict

What’s working & what to watch

Strengths 2

  • Balance sheet86/100

    Interest covered 20.5×

  • Volatility75/100

    Above average

Watchouts 3

  • Valuation27/100

    Below average

  • Profitability28/100

    1% net margin · -24% ROE

  • Growth41/100

    Rev +16.7% CAGR · earnings -49.6%

Model-based scoring. For information only — not financial advice.

What is DSwiss Inc?

, a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including beverages to assist in weight management, anti-aging creams, and products designed to enhance the health system in body. The company is listed on the PINK in USA, operating in the Consumer Defensive sector, with a market capitalisation of 5.38M.

Financial Highlights

Investment Breakdown

📈 Growth
Growth trend is developing — watch for revenue consistency over upcoming quarters.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (38)

The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorConsumer Defensive
Market Cap5.38M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.1
52 Week Low0.0211
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding207M
No. of Employees13
IndustryHousehold & Personal Products
ExchangePINK
Beta-0.813
CurrencyUSD
Websitewww.dswissbeauty.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.